CME
Reconsidering the Algorithm: nAMD
Host: Sabin Dang, MD Host: Jayanth Sridhar, MD The approval of new, more durable treatments is an exciting development for the management of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME), but how do the